1 Elsheikh, B. et al. Correlation of single-breath count test and neck flexor muscle strength with spirometry in myasthenia gravis. Muscle Nerve 53, 134-136, doi:10.1002/mus.24929 (2016) PMC4715713
2 Agurto, C. et al. Analyzing progression of motor and speech impairment in ALS. Annu Int Conf IEEE Eng Med Biol Soc 2019, 6097-6102, doi:10.1109/EMBC.2019.8857300 (2019)
3 Kalia, S. S. et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genetics in medicine : official journal of the American College of Medical Genetics 19, 249-255, doi:10.1038/gim.2016.190 (2017)
4 McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research 20, 1297-1303, doi:10.1101/gr.107524.110 (2010) PMC2928508
5 DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491-498, doi:10.1038/ng.806 (2011) PMC3083463
6 Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research 38, e164, doi:10.1093/nar/gkq603 (2010) 2938201
7 Li, M. X., Gui, H. S., Kwan, J. S., Bao, S. Y. & Sham, P. C. A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases. Nucleic acids research 40, e53, doi:10.1093/nar/gkr1257 (2012) 3326332
8 Solomon, B. D., Nguyen, A. D., Bear, K. A. & Wolfsberg, T. G. Clinical genomic database. Proceedings of the National Academy of Sciences of the United States of America 110, 9851-9855, doi:10.1073/pnas.1302575110 (2013) 3683745
9 Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F. & Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic acids research 43, D789-798, doi:10.1093/nar/gku1205 (2015) 4383985
10 Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic acids research 44, D862-868, doi:10.1093/nar/gkv1222 (2016) 4702865
11 Green, R. C. et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in medicine : official journal of the American College of Medical Genetics 15, 565-574, doi:10.1038/gim.2013.73 (2013) 3727274
12 Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 278, 1349-1356 (1997)
13 Abel, O. et al. Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD). JMIR mHealth and uHealth 1, e18, doi:10.2196/mhealth.2706 (2013) 4114449
14 Pinero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic acids research 45, D833-D839, doi:10.1093/nar/gkw943 (2017) 5210640
15 Sim, N. L. et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic acids research 40, W452-457, doi:10.1093/nar/gks539 (2012) 3394338
16 Chun, S. & Fay, J. C. Identification of deleterious mutations within three human genomes. Genome research 19, 1553-1561, doi:10.1101/gr.092619.109 (2009) 2752137
17 Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nature methods 7, 575-576, doi:10.1038/nmeth0810-575 (2010)
18 Li, M. X. et al. Predicting mendelian disease-causing non-synonymous single nucleotide variants in exome sequencing studies. PLoS genetics 9, e1003143, doi:10.1371/journal.pgen.1003143 (2013) 3547823
19 Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S. & Goldstein, D. B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS genetics 9, e1003709, doi:10.1371/journal.pgen.1003709 (2013) 3749936
20 Itan, Y. et al. The human gene damage index as a gene-level approach to prioritizing exome variants. Proceedings of the National Academy of Sciences of the United States of America 112, 13615-13620, doi:10.1073/pnas.1518646112 (2015) 4640721
21 Fadista, J., Oskolkov, N., Hansson, O. & Groop, L. LoFtool: a gene intolerance score based on loss-of-function variants in 60 706 individuals. Bioinformatics 33, 471-474, doi:10.1093/bioinformatics/btv602 (2017)
22 Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, doi:10.1126/science.1260419 (2015)
23 Consortium, G. T. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660, doi:10.1126/science.1262110 (2015) PMC4547484
24 Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585, doi:10.1038/ng.2653 (2013) PMC4010069
25 Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285-291, doi:10.1038/nature19057 (2016) 5018207
26 Tennessen, J. A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64-69, doi:10.1126/science.1219240 (2012) 3708544
27 Auton, A. et al. A global reference for human genetic variation. Nature 526, 68-74, doi:10.1038/nature15393 (2015) 4750478
28 Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome research 22, 1790-1797, doi:10.1101/gr.137323.112 (2012) 3431494
29 Consortium, E. P. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306, 636-640, doi:10.1126/science.1105136 (2004)
30 Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100, doi:10.1038/nature11245 (2012) PMC4154057
31 Barrett, T. et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic acids research 37, D885-890, doi:10.1093/nar/gkn764 (2009) 2686538
32 Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective microRNA target sites in mammalian mRNAs. eLife 4, doi:10.7554/eLife.05005 (2015) 4532895
33 Griffiths-Jones, S. The microRNA Registry. Nucleic acids research 32, D109-111, doi:10.1093/nar/gkh023 (2004) 308757
34 Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A. & Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic acids research 34, D140-144, doi:10.1093/nar/gkj112 (2006) 1347474
35 Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: tools for microRNA genomics. Nucleic acids research 36, D154-158, doi:10.1093/nar/gkm952 (2008) 2238936
36 Anders, S., Pyl, P. T. & Huber, W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166-169, doi:10.1093/bioinformatics/btu638 (2015) 4287950
37 Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology 15, 550, doi:10.1186/s13059-014-0550-8 (2014) 4302049
38 Milani, P. et al. Cell freezing protocol suitable for ATAC-Seq on motor neurons derived from human induced pluripotent stem cells. Sci Rep 6, 25474, doi:10.1038/srep25474 (2016) PMC4857123
39 Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome biology 9, R137, doi:10.1186/gb-2008-9-9-r137 (2008) PMC2592715
40 Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576-589, doi:10.1016/j.molcel.2010.05.004 (2010) PMC2898526
41 Holewinski, R. J., Parker, S. J., Matlock, A. D., Venkatraman, V. & Van Eyk, J. E. Methods for SWATH: Data Independent Acquisition on TripleTOF Mass Spectrometers. Methods Mol Biol 1410, 265-279, doi:10.1007/978-1-4939-3524-6_16 (2016)
42 Kirk, J. A. et al. Pacemaker-induced transient asynchrony suppresses heart failure progression. Science translational medicine 7, 319ra207, doi:10.1126/scitranslmed.aad2899 (2015) 4858435
43 Parker, S. J., Venkatraman, V. & Van Eyk, J. E. Effect of peptide assay library size and composition in targeted data-independent acquisition-MS analyses. Proteomics 16, 2221-2237, doi:10.1002/pmic.201600007 (2016)
44 Alexander, D. H., Novembre, J. & Lange, K. Fast model-based estimation of ancestry in unrelated individuals. Genome research 19, 1655-1664, doi:10.1101/gr.094052.109 (2009) PMC2752134
45 Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68-74, doi:10.1038/nature15393 (2015) PMC4750478
46 Patterson, N., Price, A. L. & Reich, D. Population structure and eigenanalysis. PLoS genetics 2, e190, doi:10.1371/journal.pgen.0020190 (2006) PMC1713260
47 McVean, G. A genealogical interpretation of principal components analysis. PLoS genetics 5, e1000686, doi:10.1371/journal.pgen.1000686 (2009) PMC2757795
48 Galinsky, K. J. et al. Fast Principal-Component Analysis Reveals Convergent Evolution of ADH1B in Europe and East Asia. Am J Hum Genet 98, 456-472, doi:10.1016/j.ajhg.2015.12.022 (2016) PMC4827102
49 Fabian Pedregosa, G. V., Alexandre Gramfort, Vincent Michel, Bertrand Thirion, Olivier Grisel, Mathieu Blondel, Andreas Müller, Joel Nothman, Gilles Louppe, Peter Prettenhofer, Ron Weiss, Vincent Dubourg, Jake Vanderplas, Alexandre Passos, David Cournapeau, Matthieu Brucher, Matthieu Perrot, Édouard Duchesnay. Scikit-learn: Machine Learning in Python. Journal of Machine Learning Research doi: arXiv:1201.0490 (2012)
50 Alsultan, A. A., Waller, R., Heath, P. R. & Kirby, J. The genetics of amyotrophic lateral sclerosis: Current insights. Degener. Neurol. Neuromuscul. Dis. 6, 49–64, doi:10.2147/DNND.S84956 (2016) PMC6053097
51 Mejzini, R. et al. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci 13, 1310, doi:10.3389/fnins.2019.01310 (2019) PMC6909825
52 Sato, K. et al. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function. J Biol Chem 293, 17135-17153, doi:10.1074/jbc.RA118.003849 (2018) PMC6222102
53 Hadano, S. et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet 29, 166-173, doi:10.1038/ng1001-166 (2001)
54 Greenway, M. J. et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38, 411-413, doi:10.1038/ng1742 (2006)
55 Wu, D. et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 62, 609-617, doi:10.1002/ana.21221 (2007) PMC2776820
56 Bradshaw, W. J. et al. Structural insights into human angiogenin variants implicated in Parkinson's disease and Amyotrophic Lateral Sclerosis. Sci Rep 7, 41996, doi:10.1038/srep41996 (2017) PMC5296752
57 Rutherford, N. J. et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS genetics 4, e1000193, doi:10.1371/journal.pgen.1000193 (2008) PMC2527686
58 Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672, doi:10.1126/science.1154584 (2008)
59 Mackenzie, I. R. & Rademakers, R. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol 21, 693-700, doi:10.1097/WCO.0b013e3283168d1d (2008) PMC2869081
60 Koppers, M. et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33, 837 e837-813, doi:10.1016/j.neurobiolaging.2011.10.006 (2012)
61 Dolzhenko, E. et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome research 27, 1895-1903, doi:10.1101/gr.225672.117 (2017) PMC5668946
62 Shiga, A. et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One 7, e43120, doi:10.1371/journal.pone.0043120 (2012) PMC3416794
63 Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74, doi:10.1038/nature11247 (2012) PMC3439153
64 Zhang, H. et al. Subgroup analysis reveals molecular heterogeneity and provides potential precise treatment for pancreatic cancers. Onco Targets Ther 11, 5811-5819, doi:10.2147/OTT.S163139 (2018) PMC6140745
65 Ashley, E. A. Towards precision medicine. Nat Rev Genet 17, 507-522, doi:10.1038/nrg.2016.86 (2016)
66 Nicolas, A. et al. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 97, 1268-1283 e1266, doi:10.1016/j.neuron.2018.02.027 (2018) PMC5867896
67 Kwart, D. et al. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP beta-CTFs, Not Abeta. Neuron 104, 256-270 e255, doi:10.1016/j.neuron.2019.07.010 (2019)
68 Karch, C. M. et al. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies. Stem Cell Reports 13, 939-955, doi:10.1016/j.stemcr.2019.09.006 (2019) PMC6895712
69 Li, Y. et al. A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells. PLoS One 10, e0118266 (2015)